Über das Unternehmen
- Firmenname (rechtlich): Hangzhou Longshine Bio-Tech Co., Ltd.
- Internationaler Name: Hangzhou Longshine Bio-Tech Co., Ltd., Hangzhou, Zhejiang, China
- Marke / Handelsname: Longshine Bio-Tech
- Registrierungsland: China
- Adresse: China Mainland Zhejiang Hangzhou 5-405, Matrix International Center, No. 515, Yuhangtang Road, Gongshu District, Hangzhou • Zhejiang
Beschreibung:
Founded in 2011 and headquartered in Gongshu District, Hangzhou, Hangzhou Longshine Bio-Tech Co., Ltd. manufactures and trades active pharmaceutical ingredients, intermediates, bio products, and natural extracts, including chiral intermediates and prophylactic biological products. The company became an approved supplier to Bayer in 2013, earned ISO 9001 certification in 2017, and in 2018 invested in the Dalian Wondersun API and vitamins factory. Its customers include Bayer, Cipla, Sun Pharma, and Hikma, and it offers CDMO services along with OEM production, shipping on FOB, CIF, CIP, CPT, or DDP terms with L/C, T/T, or D/P payment, competing on brand strength, R&D experience, delivery speed, production capacity, and a broad product line.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
LieferantExporteurVertriebspartnerDienstleisterAgentur / VertreterHersteller
Naturextrakte & Pflanzliche Rohstoffe
HerstellerVertriebspartnerDienstleisterAgentur / Vertreter
Pharmazeutische Chemikalien
HerstellerVertriebspartnerDienstleisterAgentur / Vertreter
Labor- & Analysedienstleistungen
HerstellerVertriebspartnerDienstleisterAgentur / Vertreter
Absatzmärkte
- Eastern Europe: Bulgaria, Czech Republic, Hungary
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Active Pharmaceutical Ingredients
- Pharmazeutische Chemikalien: 4,5-Dimethoxy-1-cyanobenzocyclobutane, API & INTERMEDIATES, 2.2.2-Trifluoroethyl Trifluoromethanesulfonate, Cyclopenta[2,1-b;3,4-b']dithiophen-4-one, CAL-101, 1,1,1-Trifluoro-2-(trifluoromethyl)pent-4-en-2-ol, 7, 8-Dimethoxy-1,3,4,5-tetrahydro-benzo[D]Azepin-2-one, Methoxyphenyl acetone, (R)-3,6-diethoxy-2,5-dihydro-2-isopropylpyrazine, Growth hormone products
- Biopharmazeutische Produkte: Marbofloxacin, 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride, Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid, (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile, Boc-3-Hydroxy-1-adamantyl-D-glycine, (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester, 2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile, (S)-3-1-Dimethylamino Ethyl Phenol, 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tat, Fondaparinux sodium, 5-Bromo-2,4-dichloropyrimidine, β-Amino-α-hydroxycyclobutanebutanamide Hydrochloride, 1-[[2-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-, methyl ester, 1-(2-cyanobiphenyl-4-yl-methyl)- 2-ethoxybenzimidazole-7-carboxylic acid ethyl ester, 1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-(2-nitropropyl)-1H-indole-7-carbonitrile, 1-(3-methyl-1-phenyl-1H-pyrazole-5-yl) piprazine, 1-BENZYL-4-methyl PIPERIDINE-3-ONE, 17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate, (1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium, (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane hydrochloride, (1S,3aR,6aS)-butyl octahydrocyclopenta[c]pyrrole-1-carboxylate oxalate, (1S,3R,4S)-2-amino-9-[4-(benzyloxy)-3-(benzyloxymethyl)-2-methylidene-cyclopentyl]-3H-purin-6-one, 2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one, 2-(4-fluorophenyl)-5-(5-bromo-2-methylbenzyl)thiophene, 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate, 2,3-Dichloro-6-nitrobenzaldehyde, 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide, 2,6-Dilfuorobenzyl Bromide, (2R,4R) 4-METHYL 2-PIPERIDINE CARBOXYLIC ACID, (2R,4R) ETHYL- 4-METHYL 2-PIPERIDINE CARBOXYLATE, (2S)-4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate, [{(2S,3S,5S)-2-Amino-3-hydroxy-5-(tert-butyloxycarbonyl)amino-1,6-diphenyl hexane} Succinic acid sa, 3'-amino-2'-hydroxy-biphenyl-carboxylic acid, 3-Fluoro-4-methylphenylisothiocyanate, (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahy, 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-5-yl)ethylbenzoic acid, 4-Bromo-2-fluoro-N-methylbenzamide, 4-Oxo-1,4-Dihydroquinoloine -3-Carboxylic Acid, 5-(1-Piperazinyl)benzofuran-2-carboxamide, 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H- indole-7-carbonitrile(2R,3R)-2,3-dih, 5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole, 5-((Z)-(5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid, 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone, Arsenazo III, Benzyl2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl) propan-2-yl, Carnidazole, Conjugated Estrogens (GMP, COS), Cyclopenta[c]pyrrole-1-carboxylic acid, octahydro-, ethyl ester, hydrochloride, (1S,3aR,6aS)-, Dapoxetine HCL, Diethyl 2-(acetamido)-2-(2-(4-octylphenyl)ethyl)propanedioate, Diethyl (3-Pyridyl) Borane, (E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, Ethyl-2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate, Ethyl-5amino-1-benzofuran-2carboxylate, Ethyl 2-(imidazo[1,2-a]pyridin-3-yl)acetate, ETHYL[(2,3-DICHLORO-6-NITRO-BENZYL)AMINO]ACETATE, LORCASERIN, N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine, N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide, N-methyl-2-sulfanylbenzamide, N-Methyl-N-((3R,4R)-4-methylpiperidin-3yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, Praziquantel (FDA), (S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoic acid, (S)-2-Naphthalenamine, 1,2,3,4-tetrahydro-5-hydroxy-N-propyl-, hydrobromide, Tert-Butyl(1R,2S,5S)-2-zido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate, (Z)-ethyl 2-chloro-2-(2-(4-Methoxyphenyl)hydrazono)acetate
Unsere Produkte & Dienstleistungen
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Sell · Pharma Chemicals
Sell · Biopharmaceutical Products
Sell · Biopharmaceutical Products
Certifications
ISO9001
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen